Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Reduced Dose Craniospinal Radiation (1800 cGy) and Chemotherapy in children with newly-diagnosed standard-risk posterior fossa primitive neuro-ectodermal tumor (PNET/medulloblastoma )

		Phase:		Phase 3

		Treatment ID#:		804 CHP 693

		Age Group:		Pediatric Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Age 3 - 21 years at diagnosis Histology Proven Posterior Fossa PNET No metastatic disease Residual tumor volume less than 1.5 cubic centimeters Must begin radiotherapy before 30 days from surgery

		Last Updated:		11/26/2005

		Tumor Types:		Medulloblastoma PNET Tumor


		Comments:		Radiation Therapy: 5580 cGy tumor bed, conformal techniques; 1800 cGy craniospinal Concurrent chemotherapy during radiation with vincristine. Maintenance chemotherapy delivered after RT in an AABAABAAB pattern: CCNU, Vincristine, Cisplatinum (Regimen A) Cyclophosphamide, VP-16 (Regimen B)

		Treatment Type:		Chemotherapy Radiation

		Contact:		Anna J. Janss MD, Phd Winship Cancer Institute Emory University Egleston, GA 30322 USA Phone: 404-257-3480 Fax: E-mail: Website:

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By